Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate
Javier Villadiego, Juan García‐Arriaza, Reposo Ramírez‐Lorca, Roberto García‐Swinburn, Daniel Cabello-Rivera, Alicia E. Rosales‐Nieves, María I. Álvarez-Vergara, Fernando Cala-Fernández, Ernesto García‐Roldán, Juan L. López-Ogáyar, Carmen Zamora, David Astorgano, Guillermo Albericio, Patricia Pérez, Ana M. Muñoz-Cabello, Alberto Pascual, Mariano Estéban, José López‐Barneo, Juan José Toledo‐Aral
Topics & Concepts
VacciniaVirologyViral replicationVirusBiologyCoronavirusTransgeneGenetically modified mouseBrain damageImmunologyMedicineCoronavirus disease 2019 (COVID-19)DiseaseNeuroscienceInfectious disease (medical specialty)PathologyGeneRecombinant DNAGeneticsSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies